Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave
- PMID: 33653336
- PMCID: PMC7922722
- DOI: 10.1186/s12967-021-02762-0
Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave
Conflict of interest statement
PAA reports grants and personal fees from BMS, Roche-Genentech, Array; personal fees from MSD, Novartis, Merck Serono, Pierre Fabre, Incyte, Genmab, NewLink Genetics, Medimmune, AstraZeneca, Syndax, Sun Pharma, Sanofi, Idera, Ultimovacs, Sandoz, Immunocore, 4SC, Alkermes, Italfarmaco, Nektar and Boehringer-Ingelheim, all outside the submitted work. The other authors declare that they have no competing interests.
Figures

Comment on
-
Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China.Nat Commun. 2020 Nov 20;11(1):5917. doi: 10.1038/s41467-020-19802-w. Nat Commun. 2020. PMID: 33219229 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous